Effect of low anterior resection syndrome on quality of life in colorectal cancer patients: A retrospective observational study

Table 3 Low anterior resection syndrome is correlated with clinicopathological features of colorectal cancer patients

	Low LARS score (n = 99)	High LARS score (n = 124)	P value
Age (yr): < 59/≥ 60	49 (49.5%)/50 (50.5%)	62 (50.0%)/62 (50.0%)	0.524
Sex: Male/female	73 (73.4%)/26 (26.3%)	81 (65.3%)/43 (34.6%)	0.114
Tumor size (cm): < 4/≥ 4	44 (44.4%)/52 (55.6%)	69 (55.6%)/49 (44.4%)	0.044
Length (cm): < 12/≥ 12	25 (25.3%)/63 (74.7%)	25 (23.1%)/83 (76.8%)	0.249
Length of distal margin (cm): < 3/≥ 3	43 (52.4%)/39 (47.6%)	52 (57.1%)/39 (42.8%)	0.32
T: 0, 1/2, 3	10 (15.1%)/56 (84.8%)	13 (17.6%)61 (82.4%)	0.439
N: < 17/≥ 17	60 (61.8%)/37 (38.1%)	77 (63.1%)/45 (36.9%0	0.479
M: No/yes	86 (92.5%)/7 (7.5%)	86 (89.6%)/10 (10.4%)	0.331
Differentiated degree: 0, 1/2, 3	31 (31.9%)/66 (68.1%0	45 (37.8%)/74 (62.2%)	0.264
TME/PME	59 (62.1%)/39 (37.9%)	58 (47.5%)/64 (52.4%)	0.041
Anal distance: < 9/≥ 9(cm)	41 (41.8%)/57 (58.2%)	62 (51%)/60 (49%)	0.117
Fistulation: No/yes	53 (53.5%)/46 (46.5%)	50 (41.3%)/71 (58.7%)	0.005
Preoperation radiotherapy: No/yes	79 (81.4%)/18 (18.6%)	79 (64.7%)/43 (35.1%)	0.0211
Neoadjuvant chemotherapy: No/yes	84 (85.7%)/14 (24.3%)	84 (68.3%)/39 (31.7%)	0.0072

¹P ≤ 0.05.

²P ≤ 0.001, statistically significant difference.

T: Tumor; N: Node; M: Metastasis; TME/PME: Total/partial mesorectal excision.